News Chart Aptamer Sciences Inc

Equities

A291650

KR7291650000

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-18 pm EDT			5-day change	1st Jan Change
2,595 ^KRW	-3.89%		-10.05%	-28.02%

Mar. 26	Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	CI
2022	Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	CI

aaa3e0240503d74578a79dce1a.WUDRFPkAqPSODCYugupz5oVi4oUsH9wMW4J4PJclcUQ.CgmrTJ1pmp3JZhde1IQgnLUB2-BJKYt8IuY0U-1wBi8hH7V_kW7-ut5tTQ~c9c2632c2f1a55ed1d06f06969f655f3